Lonsurf Received a New Indication, in Combination With Bevacizumab, for Previously Treated Metastatic Colorectal Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 223
- Publication type:
- Article
Works matching IS 21641153 AND DT 2023 AND VI 13 AND IP 4
Results: 10
1
2
Talzenna Received a New Indication, With Enzalutamide, for Metastatic Castration-Resistant Prostate Cancer With HRR Gene Mutation.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 222
- Publication type:
- Article
3
Jemperli Plus Chemotherapy Now FDA Approved for Front-Line Treatment of dMMR or MSI-H Endometrial Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 221
- Publication type:
- Article
4
Vanflyta Now Approved for Newly Diagnosed FLT3-ITD--Positive AML.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 220
- Publication type:
- Article
5
FDA Accelerated the Approval of Columvi for Selected Relapsed or Refractory Large B-Cell Lymphomas.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 220
- Publication type:
- Article
6
Impact of Pharmacist-Led Oral Chemotherapy Telehealth Clinic at a Community Cancer Center Using the TAMER Model.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 211
- By:
- Publication type:
- Article
7
A Review of Clinical Data Among Biosimilars: Just How Similar Are They?
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 199
- By:
- Publication type:
- Article
8
Duration of Response to PARP Inhibitors for Maintenance Treatment of Ovarian Cancer in Patients With Germline or Somatic HRD.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 192
- By:
- Publication type:
- Article
9
Effects of Levofloxacin Prophylaxis in Pediatric Patients With Acute Myeloid Leukemia, Relapsed Acute Lymphoblastic Leukemia, or Patients Undergoing Hematopoietic Stem Cell Transplant.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 185
- By:
- Publication type:
- Article
10
Effects of Vascular Endothelial Growth Factor Inhibitor--Induced Proteinuria on Treatment Course and Outcomes: Retrospective Analysis and Review of the Literature.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 4, p. 178
- By:
- Publication type:
- Article